Protective Host Response to Parasite and Its Limitations

American Trypanosomiasis

Volumn , Issue , 2010, Pages 601-668

  Truyens, Carine ^a   Carlier, Yves ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882324854     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384876-5.00024-1     Document Type: Chapter

References (442)

1. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 1995, 155:3955-3963.
2. Acosta Rodriguez E.V., Zuniga E.I., Montes C.L., Merino M.C., Bermejo D.A., Amezcua Vesely M.C., et al. Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first?. Scand. J. Immunol. 2007, 66:137-142.
3. Affranchino J.L., Ibanez C.F., Luquetti A.O., Rassi A., Reyes M.B., Macina R.A., et al. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas? disease. Mol. Biochem. Parasitol. 1989, 34:221-228.
4. Agusti R., Couto A.S., Alves M.J., Colli W., Lederkremer R.M. Lipids shed into the culture medium by trypomastigotes of Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 2000, 95:97-102.
5. Ahmed R., Bevan M.J., Reiner S.L., Fearon D.T. The precursors of memory: models and controversies. Nat. Rev. Immunol. 2009, 9:662-668.
6. Akashi-Takamura S., Miyake K. TLR accessory molecules. Curr. Opin. Immunol. 2008, 20:420-425.
7. Alba Soto C.D., Mirkin G.A., Solana M.E., Gonzalez Cappa S.M. Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. Infect. Immun. 2003, 71:1194-1199.
8. Albareda M.C., Laucella S.A., Alvarez M.G., Armenti A.H., Bertochi G., Tarleton R.L., et al. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int. Immunol. 2006, 18:465-471.
9. Albareda M.C., Olivera G.C., Laucella S.A., Alvarez M.G., Fernandez E.R., Lococo B., et al. Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J. Immunol. 2009, 183:4103-4108.
10. Alcaide P., Fresno M. The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through l-selectin. Int. Immunol. 2004, 16:1365-1375.
11. Alcaide P., Lim Y.C., Luscinskas F.W., Fresno M. Mucin AgC10 from Trypanosoma cruzi interferes with l-selectin-mediated monocyte adhesion. Infect. Immun. 2010, 78:1260-1268.
12. Aliberti J.C., Cardoso M.A., Martins G.A., Gazzinelli R.T., Vieira L.Q., Silva J.S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 1996, 64:1961-1967.
13. Aliberti J., Viola J.P., Vieira-de-Abreu A., Bozza P.T., Sher A., Scharfstein J. Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J. Immunol. 2003, 170:5349-5353.
14. Almeida I.C., Gazzinelli R.T. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 2001, 70:467-477.
15. Almeida I.C., Ferguson M.A., Schenkman S., Travassos L.R. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 1994, 304(Pt 3):793-802.
16. Alvarez M.G., Postan M., Weatherly D.B., Albareda M.C., Sidney J., Sette A., et al. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl. Trop. Dis. 2008, 2:e288.
17. Amith S.R., Jayanth P., Franchuk S., Finlay T., Seyrantepe V., Beyaert R., et al. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal. 2010, 22:314-324.
18. Andrews N.W., Robbins E.S., Ley V., Hong K.S., Nussenzweig V. Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi. J. Exp. Med. 1988, 167:300-314.
19. Antunez M.I., Cardoni R.L. IL-12 and IFN-gamma production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol. Lett. 2000, 71:103-109.
20. Antunez M.I., Cardoni R.L. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol. Lett. 2001, 79:189-196.
21. Aoki M.P., Cano R.C., Pellegrini A.V., Tanos T., Guinazu N.L., Coso O.A., et al. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. Microbes Infect. 2006, 8:1723-1731.
22. Appay V., Rowland-Jones S.L. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin. Immunol. 2004, 16:205-212.
23. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002, 8:379-385.
24. Araujo-Jorge T., el Bouhdidi A., Rivera M.T., Daeron M., Carlier Y. Trypanosoma cruzi infection in mice enhances the membrane expression of low-affinity Fc receptors for IgG and the release of their soluble forms. Parasite Immunol. 1993, 15:539-546.
25. Araujo-Jorge T., Rivera M.T., el Bouhdidi A., Daeron M., Carlier Y. An Fc gamma RII-, Fc gamma RIII-specific monoclonal antibody (2.4G2) decreases acute Trypanosoma cruzi infection in mice. Infect. Immun. 1993, 61:4925-4928.
26. Araujo-Jorge T.C., de Meirelles M.N., Isaac L. Trypanosoma cruzi: killing and enhanced uptake by resident peritoneal macrophages treated with alpha-2-macroglobulin. Parasitol. Res. 1990, 76:545-552.
27. Araujo-Jorge T.C., Lage M.J., Rivera M.T., Carlier Y., Van Leuven F. Trypanosoma cruzi: enhanced alpha-macroglobulin levels correlate with the resistance of BALB/cj mice to acute infection. Parasitol. Res. 1992, 78:215-221.
28. Araujo F.F., Gomes J.A., Rocha M.O., Williams-Blangero S., Pinheiro V.M., Morato M.J., et al. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci. 2007, 12:2797-2806.
29. Argibay P.F., Di Noia J.M., Hidalgo A., Mocetti E., Barbich M., Lorenti A.S., et al. Trypanosoma cruzi surface mucin TcMuc-e2 expressed on higher eukaryotic cells induces human T cell anergy, which is reversible. Glycobiology 2002, 12:25-32.
30. Arruda Hinds L.B., Alexandre-Moreira M.S., Decote-Ricardo D., Nunes M.P., Pecanha L.M. Increased immunoglobulin secretion by B lymphocytes from Trypanosoma cruzi infected mice after B lymphocytes-natural killer cell interaction. Parasite Immunol. 2001, 23:581-586.
31. Bafica A., Santiago H.C., Goldszmid R., Ropert C., Gazzinelli R.T., Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 2006, 177:3515-3519.
32. Banchereau J., Klechevsky E., Schmitt N., Morita R., Palucka K., Ueno H. Harnessing human dendritic cell subsets to design novel vaccines. Ann. N. Y. Acad. Sci. 2009, 1174:24-32.
33. Bartholomeu D.C., Ropert C., Melo M.B., Parroche P., Junqueira C.F., Teixeira S.M., et al. Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. J. Immunol. 2008, 181:1333-1344.
34. Bastos K.R., Barboza R., Sardinha L., Russo M., Alvarez J.M., Lima M.R. Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. J. Interferon Cytokine Res. 2007, 27:399-410.
35. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 2005, 26:347-362.
36. Beetz S., Wesch D., Marischen L., Welte S., Oberg H.H., Kabelitz D. Innate immune functions of human gammadelta T cells. Immunobiology 2008, 213:173-182.
37. Bekpen C., Marques-Bonet T., Alkan C., Antonacci F., Leogrande M.B., Ventura M., et al. Death and resurrection of the human IRGM gene. PLoS Genet. 2009, 5:e1000403.
38. Bendelac A. Innate-like lymphocytes. Curr. Opin. Immunol. 2006, 18:517-518.
39. Bento C.A., Melo M.B., Previato J.O., Mendonca-Previato L., Pecanha L.M. Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro. J. Immunol. 1996, 157:4996-5001.
40. Berasain P., Carmona C., Frangione B., Cazzulo J.J., Goni F. Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 2003, 130:23-29.
41. Bergeron M., Blanchette J., Rouleau P., Olivier M. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages. Parasite Immunol. 2008, 30:280-292.
42. Beucher M., Norris K.A. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family. Infect. Immun. 2008, 76:750-758.
43. Beutler B.A. TLRs and innate immunity. Blood 2009, 113:1399-1407.
44. Bontempi E., Cazzulo J.J. Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. FEMS Microbiol. Lett. 1990, 58:337-341.
45. Borges M., Da Silva A.C., Sereno D., Ouaissi A. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor. Immunology 2003, 109:147-155.
46. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003, 101:2711-2720.
47. Brener Z. Immunity to Trypanosoma cruzi. Adv. Parasitol. 1980, 18:247-292.
48. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 1997, 114:103-110.
49. Brodskyn C., Patricio J., Oliveira R., Lobo L., Arnholdt A., Mendonca-Previato L., et al. Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect. Immun. 2002, 70:3736-3743.
50. Brodskyn C.I., Silva A.M., Takehara H.A., Mota I. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi. Immunol. Cell Biol. 1989, 67(Pt 6):343-348.
51. Brodskyn C.I., Barral A., Bulhoes M.A., Souto T., Machado W.C., Barral-Netto M. Cytotoxicity in patients with different clinical forms of Chagas' disease. Clin. Exp. Immunol. 1996, 105:450-455.
52. Bronte V., Serafini P., Mazzoni A., Segal D.M., Zanovello P. l-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 2003, 24:302-306.
53. Brunner C., Muller B., Wirth T. Bruton's tyrosine kinase is involved in innate and adaptive immunity. Histol. Histopathol. 2005, 20:945-955.
54. Buckner F.S., Wipke B.T., Van Voorhis W.C. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 1997, 27:2541-2548.
55. Budzko D.B., Pizzimenti M.C., Kierszenbaum F. Effects of complement depletion in experimental Chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Infect. Immun. 1975, 11:86-91.
56. Buscaglia C.A., Campo V.A., Frasch A.C., Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 2006, 4:229-236.
57. Buschiazzo A., Goytia M., Schaeffer F., Degrave W., Shepard W., Gregoire C., et al. Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase. Proc. Natl. Acad. Sci. USA 2006, 103:1705-1710.
58. Bustamante J.M., Bixby L.M., Tarleton R.L. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 2008, 14:542-550.
59. Cabral H.R., Novak I.T., Glocker T.M., Castro Viera G.A. Chagas cardiopathy: identification and quantification of infiltrating cells in the hearts of cardiac death patients of different ages. Rev. Fac. Cien. Med. Univ. Nac. Cordoba 2002, 59:83-89.
60. Camargo M.M., Almeida I.C., Pereira M.E., Ferguson M.A., Travassos L.R., Gazzinelli R.T. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 1997, 158:5890-5901.
61. Camargo M.M., Andrade A.C., Almeida I.C., Travassos L.R., Gazzinelli R.T. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J. Immunol. 1997, 159:6131-6139.
62. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 2001, 167:416-423.
63. Campos M.A., Closel M., Valente E.P., Cardoso J.E., Akira S., Alvarez-Leite J.I., et al. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol. 2004, 172:1711-1718.
64. Campos-Neto A., Suffia I., Cavassani K.A., Jen S., Greeson K., Ovendale P., et al. Cloning and characterization of a gene encoding an immunoglobulin-binding receptor on the cell surface of some members of the family Trypanosomatidae. Infect. Immun. 2003, 71:5065-5076.
65. Cardillo F., Falcao R.P., Rossi M.A., Mengel J. An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection. Eur. J. Immunol. 1993, 23:2597-2605.
66. Cardillo F., Voltarelli J.C., Reed S.G., Silva J.S. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect. Immun. 1996, 64:128-134.
67. Cardillo F., Nomizo A., Mengel J. The role of the thymus in modulating gamma delta T cell suppressor activity during experimental Trypanosoma cruzi infection. Int. Immunol. 1998, 10:107-116.
68. Carding S.R., Egan P.J. Gamma delta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2002, 2:336-345.
69. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999, 163:4647-4650.
70. Cerrone M.C., Kuhn R.E. Macrophage regulation of immune responses of spleen cells from mice infected with Trypanosoma cruzi. Cell Immunol. 1991, 138:423-436.
71. Cerrone M.C., Ritter D.M., Kuhn R.E. Effect of antigen-specific T helper cells or interleukin-2 on suppressive ability of macrophage subsets detected in spleens of Trypanosoma cruzi-infected mice as determined by limiting dilution-partition analysis. Infect. Immun. 1992, 60:1489-1498.
72. Cestari I.S., Evans-Osses I., Freitas J.C., Inal J.M., Ramirez M.I. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. J. Infect. Dis. 2008, 198:1276-1283.
73. Cestari I.S., Krarup A., Sim R.B., Inal J.M., Ramirez M.I. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol. Immunol. 2009, 47:426-437.
74. Cetron M.S., Basilio F.P., Moraes A.P., Sousa A.Q., Paes J.N., Kahn S.J., et al. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection. Am. J. Trop. Med. Hyg. 1993, 49:370-382.
75. Chaussabel D., Pajak B., Vercruysse V., Bisseye C., Garze V., Habib M., et al. Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection. Lab. Invest. 2003, 83:1373-1382.
76. Chen L., Watanabe T., Watanabe H., Sendo F. Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur. J. Immunol. 2001, 31:265-275.
77. Chessler A.D., Ferreira L.R., Chang T.H., Fitzgerald K.A., Burleigh B.A. A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fibroblasts. J. Immunol. 2008, 181:7917-7924.
78. Chessler A.D., Unnikrishnan M., Bei A.K., Daily J.P., Burleigh B.A. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection. J. Immunol. 2009, 182:2288-2296.
79. Chuenkova M.V., PereiraPerrin M. Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy. Sci. Signal. 2009, 2. ra74.
80. Cobb D., Guo S., Lara A.M., Manque P., Buck G., Smeltz R.B. T-bet-dependent regulation of CD8+ T-cell expansion during experimental Trypanosoma cruzi infection. Immunology 2009, 128:589-599.
81. Cordeiro F.D., Martins-Filho O.A., Costa Rocha M.O., Adad S.J., Correa-Oliveira R., Romanha A.J. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin. Diagn. Lab. Immunol. 2001, 8:112-118.
82. Costa V.M., Torres K.C., Mendonca R.Z., Gresser I., Gollob K.J., Abrahamsohn I.A. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J. Immunol. 2006, 177:3193-3200.
83. Cremona M.L., Campetella O., Sanchez D.O., Frasch A.C. Enzymatically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity. Glycobiology 1999, 9:581-587.
84. Cuellar A., Santander S.P., Thomas M.C., Guzman F., Gomez A., Lopez M.C., et al. Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol. Cell Biol. 2008, 86:255-260.
85. Cuellar A., Rojas F., Bolanos N., Diez H., Del Carmen T.M., Rosas F., et al. Natural CD4(+) T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patients. Immunol. Cell Biol. 2009, 87:149-153.
86. Cummings K.L., Tarleton R.L. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect. Immun. 2004, 72:4081-4089.
87. Cunningham D.S., Kuhn R.E., Rowland E.C. Suppression of humoral responses during Trypanosoma cruzi infections in mice. Infect. Immun. 1978, 22:155-160.
88. Cunningham D.S., Grogl M., Kuhn R.E. Suppression of antibody responses in humans infected with Trypanosoma cruzi. Infect. Immun. 1980, 30:496-499.
89. D'Imperio Lima M.R., Joskowicz M., Coutinho A., Kipnis T., Eisen H. Very large and isotypically atypical polyclonal plaque-forming cell responses in mice infected with Trypanosoma cruzi. Eur. J. Immunol. 1985, 15:201-203.
90. Da Mata J.R., Camargos M.R., Chiari E., Machado C.R. Trypanosoma cruzi infection and the rat central nervous system: proliferation of parasites in astrocytes and the brain reaction to parasitism. Brain Res. Bull. 2000, 53:153-162.
91. Da Silva A.C., Espinoza A.G., Taibi A., Ouaissi A., Minoprio P. A 24,000MW Trypanosoma cruzi antigen is a B-cell activator. Immunology 1998, 94:189-196.
92. de Diego J., Punzon C., Duarte M., Fresno M. Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J. Immunol. 1997, 159:4983-4989.
93. de Meis J., Mendes-da-Cruz D.A., Farias-de-Oliveira D.A., Correa-de-Santana E., Pinto-Mariz F., Cotta-de-Almeida V., et al. Atrophy of mesenteric lymph nodes in experimental Chagas' disease: differential role of Fas/Fas-L and TNFRI/TNF pathways. Microbes Infect. 2006, 8:221-231.
94. de Oliveira G.A., Gattass C.R. Acute Trypanosoma cruzi infection differentially affects CD3 and Thy-1 mediated T cell activation. Immunol. Lett. 1991, 28:227-232.
95. de Oliveira G.M., Diniz R.L., Batista W., Batista M.M., Bani C.C., Araujo-Jorge T.C., et al. Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. Am. J. Pathol. 2007, 171:79-86.
96. de Souza E.M., Araujo-Jorge T.C., Bailly C., Lansiaux A., Batista M.M., Oliveira G.M., et al. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res. 2003, 314:223-235.
97. de Souza E.M., Meuser-Batista M., Batista D.G., Duarte B.B., Araujo-Jorge T.C., Soeiro M.N. Trypanosoma cruzi: alpha-2-macroglobulin regulates host cell apoptosis induced by the parasite infection in vitro. Exp. Parasitol. 2008, 118:331-337.
98. Diana J., Lehuen A. NKT cells: friend or foe during viral infections?. Eur. J. Immunol. 2009, 39:3283-3291.
99. Ding L., Shevach E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 1992, 148:3133-3139.
100. do Carmo M.S., dos Santos M.R., Cano M.I., Araya J.E., Yoshida N., da Silveira J.F. Expression and genome-wide distribution of the gene family encoding a 90kDa surface glycoprotein of metacyclic trypomastigotes of Trypanosoma cruzi. Mol. Biochem. Parasitol. 2002, 125:201-206.
101. Docampo R., Casellas A.M., Madeira E.D., Cardoni R.L., Moreno S.N., Mason R.P. Oxygen-derived radicals from Trypanosoma cruzi-stimulated human neutrophils. FEBS Lett. 1983, 155:25-30.
102. dos Santos D.M., Talvani A., Guedes P.M., Machado-Coelho G.L., de Lana M., Bahia M.T. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. Exp. Parasitol. 2009, 121:8-14.
103. DosReis G.A. Susceptible hosts: a resort for parasites right in the eye of the immune response. An. Acad. Bras. Cienc. 2000, 72:79-82.
104. DosReis G.A., Lopes M.F. The importance of apoptosis for immune regulation in Chagas disease. Mem. Inst. Oswaldo Cruz 2009, 104(Suppl. 1):259-262.
105. Duschak V.G., Riarte A., Segura E.L., Laucella S.A. Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease. Immunol. Lett. 2001, 78:135-142.
106. Duthie M.S., Kahn M., White M., Kapur R.P., Kahn S.J. Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 2005, 73:1890-1894.
107. Duthie M.S., Kahn M., White M., Kapur R.P., Kahn S.J. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 2005, 73:181-192.
108. Duthie M.S., Kahn S.J. Treatment with alpha-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 2002, 168:5778-5785.
109. Duthie M.S., Kahn S.J. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. Int. Immunol. 2005, 17:607-613.
110. Duthie M.S., Kahn S.J. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment. Immunology 2006, 119:355-361.
111. Duthie M.S., Wleklinski-Lee M., Smith S., Nakayama T., Taniguchi M., Kahn S.J. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 2002, 70:36-48.
112. Dutra W.O., da Luz Z.M., Cancado J.R., Pereira M.E., Brigido-Nunes R.M., Galvao L.M., et al. Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol. 1996, 18:579-585.
113. Dutra W.O., Martins-Filho O.A., Cancado J.R., Pinto-Dias J.C., Brener Z., Gazzinelli G., et al. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand. J. Immunol. 1996, 43:88-93.
114. Dutra W.O., Martins-Filho O.A., Cancado J.R., Pinto-Dias J.C., Brener Z., Freeman G.L., et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int. Immunol. 1994, 6:499-506.
115. Dutra W.O., Colley D.G., Pinto-Dias J.C., Gazzinelli G., Brener Z., Pereira M.E., et al. Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand. J. Immunol. 2000, 51:91-97.
116. el Bouhdidi A., Truyens C., Rivera M.T., Bazin H., Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol. 1994, 16:69-76.
117. Emoto M., Kaufmann S.H. Liver NKT cells: an account of heterogeneity. Trends Immunol. 2003, 24:364-369.
118. Empson V.G., McQueen F.M., Dalbeth N. The natural killer cell: a further innate mediator of gouty inflammation?. Immunol. Cell Biol. 2010, 88:24-31.
119. Engman D.M., Dragon E.A., Donelson J.E. Human humoral immunity to HSP70 during Trypanosoma cruzi infection. J. Immunol. 1990, 144:3987-3991.
120. Fernandes M., Irulegui I., Deane M.P., Ruiz R.C. Trypanosoma cruzi: course of infection in platelets-depleted mice. Rev. Inst. Med. Trop. Sao Paulo 1992, 34:9-13.
121. Fernandez-Gomez R., Esteban S., Gomez-Corvera R., Zoulika K., Ouaissi A. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J. Immunol. 1998, 160:3471-3479.
122. Ferreira V., Valck C., Sanchez G., Gingras A., Tzima S., Molina M.C., et al. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J. Immunol. 2004, 172:3042-3050.
123. Fischer E., Ouaissi M.A., Velge P., Cornette J., Kazatchkine M.D. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway. Immunology 1988, 65:299-303.
124. Flechas I.D., Cuellar A., Cucunuba Z.M., Rosas F., Velasco V., Steindel M., et al. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. BMC Infect. Dis. 2009, 9:186.
125. Fonseca S.G., Moins-Teisserenc H., Clave E., Ianni B., Nunes V.L., Mady C., et al. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect. 2005, 7:688-697.
126. Frasch A.C. Trans-sialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host. Parasitology 1994, 108(Suppl.):S37-S44.
127. Frasch A.C. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 2000, 16:282-286.
128. Freire-de-Lima C.G., Nunes M.P., Corte-Real S., Soares M.P., Previato J.O., Mendonca-Previato L., et al. Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma. J. Immunol. 1998, 161:4909-4916.
129. Freire-de-Lima C.G., Nascimento D.O., Soares M.B., Bozza P.T., Castro-Faria-Neto H.C., de Mello F.G., et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000, 403:199-203.
130. Frosch S., Kuntzlin D., Fleischer B. Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity. Infect. Immun. 1997, 65:971-977.
131. Fujimura A.E., Kinoshita S.S., Pereira-Chioccola V.L., Rodrigues M.M. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 2001, 69:5477-5486.
132. Fukata M., Vamadevan A.S., Abreu M.T. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin. Immunol. 2009, 21:242-253.
133. Gaffen S.L., Liu K.D. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004, 28:109-123.
134. Gaillard T., Mulsch A., Klein H., Decker K. Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe Seyler 1992, 373:897-902.
135. Galili U., Anaraki F., Thall A., Hill-Black C., Radic M. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993, 82:2485-2493.
136. Gao W., Wortis H.H., Pereira M.A. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int. Immunol. 2002, 14:299-308.
137. Garcia F., Sepulveda P., Liegeard P., Gregoire J., Hermann E., Lemonnier F., et al. Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients. Microbes Infect. 2003, 5:351-359.
138. Garraud O., Perraut R., Riveau G., Nutman T.B. Class and subclass selection in parasite-specific antibody responses. Trends Parasitol. 2003, 19:300-304.
139. Gazzinelli R.T., Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 2006, 6:895-906.
140. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 1992, 22:2501-2506.
141. Giordanengo L., Guinazu N., Stempin C., Fretes R., Cerban F., Gea S. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 2002, 32:1003-1011.
142. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nat. Immunol. 2010, 11:197-206.
143. Godsel L.M., Tibbetts R.S., Olson C.L., Chaudoir B.M., Engman D.M. Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection. J. Clin. Microbiol. 1995, 33:2082-2085.
144. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 2003, 71:1185-1193.
145. Gomes N.A., Previato J.O., Zingales B., Mendonca-Previato L., DosReis G.A. Down-regulation of T lymphocyte activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi. Assignment of the T cell-suppressive determinant to the ceramide domain. J. Immunol. 1996, 156:628-635.
146. Goni O., Alcaide P., Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+)immature myeloid suppressor cells. Int. Immunol. 2002, 14:1125-1134.
147. Gonzalez J., Araguth M.F., Yoshida N. Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes. Infect. Immun. 1991, 59:863-867.
148. Goriely S., Cavoy R., Goldman M. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders. Allergy 2009, 64:702-709.
149. Graefe S.E., Jacobs T., Wachter U., Broker B.M., Fleischer B. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection. Parasite Immunol. 2004, 26:19-28.
150. Grauert M.R., Houdayer M., Hontebeyrie-Joskowicz M. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease. Clin. Exp. Immunol. 1993, 93:85-92.
151. Guani-Guerra E., Santos-Mendoza T., Lugo-Reyes S.O., Teran L.M. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 2010, 135(1):1-11.
152. Guillermo L.V., Silva E.M., Ribeiro-Gomes F.L., De Meis J., Pereira W.F., Yagita H., et al. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J. Leukoc. Biol. 2007, 81:942-951.
153. Guinazu N., Pellegrini A., Carrera-Silva E.A., Aoki M.P., Cabanillas A.M., Girones N., et al. Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression. Int. J. Parasitol. 2007, 37:1243-1254.
154. Hall B.S., Pereira M.A. Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect. Immun. 2000, 68:2077-2081.
155. Hall B.S., Tam W., Sen R., Pereira M.E. Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes
156. Hamada S., Umemura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J. Immunol. 2008, 181:3456-3463.
157. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003, 19:657-667.
158. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 1983, 80:3466-3469.
159. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. T lymphocyte function during experimental Chagas' disease: production of and response to interleukin 2. Eur. J. Immunol. 1985, 15:438-442.
160. Hatcher F.M., Kuhn R.E., Cerrone M.C., Burton R.C. Increased natural killer cell activity in experimental American trypanosomiasis. J. Immunol. 1981, 127:1126-1130.
161. Henriques-Pons A., Oliveira G.M., Paiva M.M., Correa A.F., Batista M.M., Bisaggio R.C., et al. Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int. J. Exp. Pathol. 2002, 83:67-79.
162. Henriques-Pons A., DeMeis J., Cotta-De-Almeida V., Savino W., Araujo-Jorge T.C. Fas and perforin are not required for thymus atrophy induced by Trypanosoma cruzi infection. Exp. Parasitol. 2004, 107:1-4.
163. Hermann E., Alonso-Vega C., Berthe A., Truyens C., Flores A., Cordova M., et al. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells. Pediatr. Res. 2006, 60:38-43.
164. Herold S., Fago A. Reactions of peroxynitrite with globin proteins and their possible physiological role. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 2005, 142:124-129.
165. Hoft D.F., Schnapp A.R., Eickhoff C.S., Roodman S.T. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect. Immun. 2000, 68:197-204.
166. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 1998, 66:1208-1215.
167. Howard J. The IRG proteins: a function in search of a mechanism. Immunobiology 2008, 213:367-375.
168. Hu X., Chakravarty S.D., Ivashkiv L.B. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 2008, 226:41-56.
169. Hume D.A. Macrophages as APC and the dendritic cell myth. J. Immunol. 2008, 181:5829-5835.
170. Hunter C.A., Slifer T., Araujo F. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect. Immun. 1996, 64:2381-2386.
171. Iida K., Whitlow M.B., Nussenzweig V. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components. J. Exp. Med. 1989, 169:881-891.
172. Inal J.M. Complement C2 receptor inhibitor trispanning: from man to schistosome. Springer Semin. Immunopathol. 2005, 27:320-331.
173. Inal J.M., Hui K.M., Miot S., Lange S., Ramirez M.I., Schneider B., et al. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. J. Immunol. 2005, 174:356-366.
174. Irigoin F., Cibils L., Comini M.A., Wilkinson S.R., Flohe L., Radi R. Insights into the redox biology of Trypanosoma cruzi: trypanothione metabolism and oxidant detoxification. Free Radic. Biol. Med. 2008, 45:733-742.
175. Jacobs F., Dubois C., Carlier Y., Goldman M. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock. Clin. Exp. Immunol. 1996, 103:233-238.
176. Jacobs F., Chaussabel D., Truyens C., Leclerq V., Carlier Y., Goldman M., et al. IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection. Clin. Exp. Immunol. 1998, 113:59-64.
177. Jacobs T., Bruhn H., Gaworski I., Fleischer B., Leippe M. NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi. Antimicrob. Agents Chemother. 2003, 47:607-613.
178. Kahn S., Wleklinski M., Aruffo A., Farr A., Coder D., Kahn M. Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor. J. Exp. Med. 1995, 182:1243-1258.
179. Kahn S.J., Nguyen D., Norsen J., Wleklinski M., Granston T., Kahn M. Trypanosoma cruzi: monoclonal antibodies to the surface glycoprotein superfamily differentiate subsets of the 85-kDa surface glycoproteins and confirm simultaneous expression of variant 85-kDa surface glycoproteins. Exp. Parasitol. 1999, 92:48-56.
180. Kayama H., Koga R., Atarashi K., Okuyama M., Kimura T., Mak T.W., et al. NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection. PLoS Pathog. 2009, 5:e1000514.
181. Kierszenbaum F. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells. J. Immunol. 1982, 129:2202-2205.
182. Kierszenbaum F., Gottlieb C.A., Budzko D.B. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection. J. Parasitol. 1981, 67:656-660.
183. Kierszenbaum F., Majumder S., Paredes P., Tanner M.K., Sztein M.B. The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulation. Mol. Biochem. Parasitol. 1998, 92:133-145.
184. Kierszenbaum F., Mejia L.H., Sztein M.B. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?. Immunology 1993, 80:445-450.
185. Kierszenbaum F., Lopez H.M., Sztein M.B. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease. Immunology 1994, 81:462-467.
186. Kim T.K., John L.S., Wieder E.D., Khalili J., Ma Q., Komanduri K.V. Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production. J. Immunol. 2009, 183:6167-6174.
187. Kipnis T.L., Krettli A.U., Dias D.S. Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments. Scand. J. Immunol. 1985, 22:217-226.
188. Knubel C.P., Martinez F.F., Fretes R.E., Diaz L.C., Theumer M.G., Cervi L., et al. Indoleamine 2,3-dioxygenase (IDO) is critical for host resistance against Trypanosoma cruzi. FASEB J. Published Mar 24, 2010, doi: 10.1096/fj.09-150920. 2010.
189. Koga R., Hamano S., Kuwata H., Atarashi K., Ogawa M., Hisaeda H., et al. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J. Immunol. 2006, 177:7059-7066.
190. Korbel D.S., Finney O.C., Riley E.M. Natural killer cells and innate immunity to protozoan pathogens. Int. J. Parasitol. 2004, 34:1517-1528.
191. Kotner J., Tarleton R. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect. Immun. 2007, 75:861-869.
192. Krautz G.M., Peterson J.D., Godsel L.M., Krettli A.U., Engman D.M. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins. Am. J. Trop. Med. Hyg. 1998, 58:137-143.
193. Krautz G.M., Kissinger J.C., Krettli A.U. The targets of the lytic antibody response against Trypanosoma cruzi. Parasitol. Today 2000, 16:31-34.
194. Krettli A.U., Brener Z. Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol. 1976, 116:755-760.
195. Krettli A.U., Cancado J.R., Brener Z. Effect of specific chemotherapy on the levels of lytic antibodies in Chagas's disease. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:334-340.
196. Krettli A.U., Pontes de Carvalho L.C. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade. Clin. Exp. Immunol. 1985, 62:270-277.
197. Krettli A.U., Weisz-Carrington P., Nussenzweig R.S. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis. Clin. Exp. Immunol. 1979, 37:416-423.
198. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 2005, 23:877-900.
199. + T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 1998, 20:207-216.
200. Kumar S., Tarleton R.L. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J. Immunol. 2001, 166:4596-4603.
201. La Flamme A.C., Kahn S.J., Rudensky A.Y., Van Voorhis W.C. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation. Eur. J. Immunol. 1997, 27:3085-3094.
202. Laderach D., Cerban F., Motran C., Vottero D.C., Gea S. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). Int. J. Parasitol. 1996, 26:1249-1254.
203. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 6:132-142.
204. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004, 5:190-198.
205. Laucella S.A., Postan M., Martin D., Hubby F.B., Albareda M.C., Alvarez M.G., et al. Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 2004, 189:909-918.
206. Leguizamon M.S., Campetella O., Russomando G., Almiron M., Guillen I., Ganzalez Cappa S.M., et al. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. J. Infect. Dis. 1994, 170:1570-1574.
207. Leguizamon M.S., Campetella O.E., Gonzalez Cappa S.M., Frasch A.C. Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity. Infect. Immun. 1994, 62:3441-3446.
208. Leguizamon M.S., Russomando G., Luquetti A., Rassi A., Almiron M., Gonzalez-Cappa S.M., et al. Long-lasting antibodies detected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured chagasic patients. J. Infect. Dis. 1997, 175:1272-1275.
209. Leguizamon M.S., Mocetti E., Garcia R.H., Argibay P., Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J. Infect. Dis. 1999, 180:1398-1402.
210. Ley V., Andrews N.W., Robbins E.S., Nussenzweig V. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J. Exp. Med. 1988, 168:649-659.
211. Li S., Yan Y., Lin Y., Bullens D.M., Rutgeerts O., Goebels J., et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 2007, 110:3926-3935.
212. Lieke T., Graefe S.E., Klauenberg U., Fleischer B., Jacobs T. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect. Immun. 2004, 72:6817-6825.
213. Lieke T., Steeg C., Graefe S.E., Fleischer B., Jacobs T. Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts. Clin. Exp. Immunol. 2006, 145:357-364.
214. Lima Pereira S.A., Dos S.V., Rodrigues D.B., Cunha Castro E.C., Dos Reis M.A., de Paula A.T.V., et al. Quantitative analysis of fibrosis and mast cells in the tongue of chronic chagasic patients: autopsy study. Med. Mal. Infect. 2007, 37:229-233.
215. Lima M.F., Kierszenbaum F. Lactoferrin effects of phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. J. Immunol. 1987, 139:1647-1651.
216. Lima M.F., Kierszenbaum F. Lactoferrin effects on the interaction of blood forms of Trypanosoma cruzi with mononuclear phagocytes. Int. J. Parasitol. 1987, 17:1205-1208.
217. Lima M.F., Beltz L.A., Kierszenbaum F. Trypanosoma cruzi: a specific surface marker for the amastigote form. J. Protozool. 1988, 35:108-110.
218. Lopes M.F., Dos Reis G.A. Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning. Infect. Immun. 1994, 62:1484-1488.
219. Lopes M.F., da Veiga V.F., Santos A.R., Fonseca M.E., DosReis G.A. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 1995, 154:744-752.
220. Lopes M.F., Freire-de-Lima C.G., DosReis G.A. The macrophage haunted by cell ghosts: a pathogen grows. Immunol. Today 2000, 21:489-494.
221. Lopes M.F., Guillermo L.V., Silva E.M. Decoding caspase signaling in host immunity to the protozoan Trypanosoma cruzi. Trends Immunol. 2007, 28:366-372.
222. Lopez H.M., Tanner M.K., Kierszenbaum F., Sztein M.B. Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes. Parasite Immunol. 1993, 15:273-280.
223. Louie M.J., Cuna W.R., Rodriguez D.C., Mayer L., Sperber K. Impairment of monocytic function during Trypanosoma cruzi infection. Clin. Diagn. Lab. Immunol. 1994, 1:707-713.
224. Low H.P., Santos M.A., Wizel B., Tarleton R.L. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J. Immunol. 1998, 160:1817-1823.
225. Lugo-Villarino G., Maldonado-Lopez R., Possemato R., Penaranda C., Glimcher L.H. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 2003, 100:7749-7754.
226. Lykens J.E., Terrell C.E., Zoller E.E., Divanovic S., Trompette A., Karp C.L., et al. Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 2010, 184:877-885.
227. Macher B.A., Galili U. The Galα1, 3Galα1, 4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim. Biophys. Acta 2008, 1780:75-88.
228. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
229. Madison M.N., Kleshchenko Y.Y., Nde P.N., Simmons K.J., Lima M.F., Villalta F. Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction. Infect. Immun. 2007, 75:4780-4791.
230. Majumder S., Kierszenbaum F. Trypanosoma cruzi immunosuppressive factor decreases the interleukin-2 mRNA level in cultured normal activated human lymphocytes. Infect. Immun. 1995, 63:4546-4549.
231. Maleckar J.R., Kierszenbaum F. Suppression of mouse lymphocyte responses to mitogens in vitro by Trypanosoma cruzi. Int. J. Parasitol. 1984, 14:45-52.
232. Manning-Cela R., Gonzalez A., Swindle J. Alternative splicing of LYT1 transcripts in Trypanosoma cruzi. Infect. Immun. 2002, 70:4726-4728.
233. Marinho C.R., Nunez-Apaza L.N., Martins-Santos R., Bastos K.R., Bombeiro A.L., Bucci D.Z., et al. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Scand. J. Immunol. 2007, 66:297-308.
234. Markine-Goriaynoff D., van der Logt J.T., Truyens C., Nguyen T.D., Heessen F.W., Bigaignon G., et al. IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 2000, 12:223-230.
235. Martin D.L., Tarleton R.L. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J. Immunol. 2005, 174:1594-1601.
236. Martin D.L., Weatherly D.B., Laucella S.A., Cabinian M.A., Crim M.T., Sullivan S., et al. CD8+T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2006, 2:e77.
237. Martin D.L., Postan M., Lucas P., Gress R., Tarleton R.L. TGF-beta regulates pathology but not tissue CD8+T cell dysfunction during experimental Trypanosoma cruzi infection. Eur. J. Immunol. 2007, 37:2764-2771.
238. Martins G.A., Cardoso M.A., Aliberti J.C., Silva J.S. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol. Lett. 1998, 63:113-120.
239. Martins G.A., Campanelli A.P., Silva R.B., Tadokoro C.E., Russo M., Cunha F.Q., et al. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection. Microbes Infect. 2004, 6:1133-1144.
240. Matta Guedes P.M., Gutierrez F.R., Maia F.L., Milanezi C.M., Silva G.K., Pavanelli W.R., et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl. Trop. Dis. 2010, 4:e604.
241. Mayer B., Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 1997, 22:477-481.
242. Medrano-Mercado N., Luz M.R., Torrico F., Tapia G., Van Leuven F., Araujo-Jorge T.C. Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia. Am. J. Trop. Med. Hyg. 1996, 54:154-161.
243. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
244. Mendes-da-Cruz D.A., De Meis J., Cotta-De-Almeida V., Savino W. Experimental Trypanosoma cruzi infection alters the shaping of the central and peripheral T-cell repertoire. Microbes Infect. 2003, 5:825-832.
245. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004, 172:2731-2738.
246. Metz G., Carlier Y., Vray B. Trypanosoma cruzi upregulates nitric oxide release by IFN-gamma-preactivated macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunol. 1993, 15:693-699.
247. Michailowsky V., Luhrs K., Rocha M.O., Fouts D., Gazzinelli R.T., Manning J.E. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infect. Immun. 2003, 71:3165-3171.
248. Michelin M.A., Silva J.S., Cunha F.Q. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 2005, 111:71-79.
249. Millar A.E., Kahn S.J. The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen. Infect. Immun. 2000, 68:3574-3580.
250. Millar A.E., Kahn S.J. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily. Exp. Parasitol. 2000, 94:84-91.
251. Millar A.E., Wleklinski-Lee M., Kahn S.J. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic. J. Immunol. 1999, 162:6092-6099.
252. Minakuchi R., Wacholtz M.C., Davis L.S., Lipsky P.E. Delineation of the mechanism of inhibition of human T cell activation by PGE2. J. Immunol. 1990, 145:2616-2625.
253. Mineo J.R., Rocha A., Costa-Cruz J.M., da Silva A.M., Silva D.A., Goncalves-Pires M.D., et al. Total and specific anti-Trypanosoma cruzi immunoglobulin E in pericardial fluid samples from patients with chronic Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:578-581.
254. Ming M., Ewen M.E., Pereira M.E. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell 1995, 82:287-296.
255. Minoprio P. Parasite polyclonal activators: new targets for vaccination approaches?. Int. J. Parasitol. 2001, 31:588-591.
256. Minoprio P., Eisen H., Joskowicz M., Pereira P., Coutinho A. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies. J. Immunol. 1987, 139:545-550.
257. Minoprio P., Bandeira A., Pereira P., Mota S.T., Coutinho A. Preferential expansion of Ly-1 B and CD4- CD8-T cells in the polyclonal lymphocyte responses to murine T. cruzi infection. Int. Immunol. 1989, 1:176-184.
258. Minoprio P., Coutinho A., Spinella S., Hontebeyrie-Joskowicz M. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. Int. Immunol. 1991, 3:427-433.
259. Minoprio P., el Cheikh M.C., Murphy E., Hontebeyrie-Joskowicz M., Coffman R., Coutinho A., et al. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J. Immunol. 1993, 151:4200-4208.
260. Miyahira Y., Katae M., Kobayashi S., Takeuchi T., Fukuchi Y., Abe R., et al. Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection. Infect. Immun. 2003, 71:3131-3137.
261. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22:240-273. Table.
262. Molina H.A., Kierszenbaum F. Kinetics of development of inflammatory lesions in myocardial and skeletal muscle in experimental Trypanosoma cruzi infection. J. Parasitol. 1988, 74:370-374.
263. Montalvao F., Almeida G.M., Silva E.M., Borges V.M., Vasconcellos R., Takiya C.M., et al. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages. Eur. J. Immunol. 2010, 40:417-425.
264. Monteiro A.C., Schmitz V., Morrot A., de Arruda L.B., Nagajyothi F., Granato A., et al. Bradykinin B2 receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog. 2007, 3:e185.
265. Monteiro A.C., Schmitz V., Svensjo E., Gazzinelli R.T., Almeida I.C., Todorov A., et al. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J. Immunol. 2006, 177:6325-6335.
266. Monteon V.M., Furuzawa-Carballeda J., Alejandre-Aguilar R., Aranda-Fraustro A., Rosales-Encina J.L., Reyes P.A. American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model. Exp. Parasitol. 1996, 83:267-274.
267. Montes C.L., Zuniga E.I., Vazquez J., Arce C., Gruppi A. Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation. Clin. Exp. Immunol. 2002, 127:27-36.
268. Montes C.L., Acosta-Rodriguez E.V., Mucci J., Zuniga E.I., Campetella O., Gruppi A. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur. J. Immunol. 2006, 36:1474-1485.
269. Morato M.J., Brener Z., Cancado J.R., Nunes R.M., Chiari E., Gazzinelli G. Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones. Am. J. Trop. Med. Hyg. 1986, 35:505-511.
270. Morgan J., Dias J.C., Gontijo E.D., Bahia-Oliveira L., Correa-Oliveira R., Colley D.G., et al. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am. J. Trop. Med. Hyg. 1996, 55:355-359.
271. Mortara R.A., Araguth M.F., Yoshida N. Reactivity of stage-specific monoclonal antibody 1G7 with metacyclic trypomastigotes of Trypanosoma cruzi strains: lytic property and 90,000mol. wt surface antigen polymorphism. Parasite Immunol. 1988, 10:369-378.
272. Mortara R.A., Minelli L.M., Vandekerckhove F., Nussenzweig V., Ramalho-Pinto F.J. Phosphatidylinositol-specific phospholipase C (PI-PLC) cleavage of GPI-anchored surface molecules of Trypanosoma cruzi triggers in vitro morphological reorganization of trypomastigotes. J. Eukaryot. Microbiol. 2001, 48:27-37.
273. Motran C.C., Cerban F.M., Rivarola W., Iosa D., Vottero D.C. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins. Exp. Parasitol. 1998, 88:223-230.
274. Moutiez M., Aumercier M., Schoneck R., Meziane-Cherif D., Lucas V., Aumercier P., et al. Purification and characterization of a trypanothione-glutathione thioltransferase from Trypanosoma cruzi. Biochem. J. 1995, 310(Pt 2):433-437.
275. Mucci J., Hidalgo A., Mocetti E., Argibay P.F., Leguizamon M.S., Campetella O. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex. Proc. Natl. Acad. Sci. USA 2002, 99:3896-3901.
276. Mucci J., Mocetti E., Leguizamon M.S., Campetella O. A sexual dimorphism in intrathymic sialylation survey is revealed by the trans-sialidase from Trypanosoma cruzi. J. Immunol. 2005, 174:4545-4550.
277. Mucci J., Risso M.G., Leguizamon M.S., Frasch A.C., Campetella O. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation. Cell Microbiol. 2006, 8:1086-1095.
278. Muller U., Kohler G., Mossmann H., Schaub G.A., Alber G., Di Santo J.P., et al. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J. Immunol. 2001, 167:3346-3353.
279. Muller U., Sobek V., Balkow S., Holscher C., Mullbacher A., Museteanu C., et al. Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur. J. Immunol. 2003, 33:70-78.
280. Munoz-Fernandez M.A., Fernandez M.A., Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol. Lett. 1992, 33:35-40.
281. Munoz-Fernandez M.A., Fernandez M.A., Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 1992, 22:301-307.
282. Nagata K., Suzuki H., Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J. Toxicol. Sci. 2007, 32:453-468.
283. Nakayasu E.S., Yashunsky D.V., Nohara L.L., Torrecilhas A.C., Nikolaev A.V., Almeida I.C. GPIomics: global analysis of glycosylphosphatidylinositol-anchored molecules of Trypanosoma cruzi. Mol. Syst. Biol. 2009, 5:261.
284. Nargis M., Chisty M.M., Ihama Y., Sato H., Inaba T., Kamiya H. Kinetics of Trypanosoma cruzi infection in guinea-pigs, with special reference to the involvement of epidermal Langerhans' cells in the induction of immunity. Parasitology 2001, 123:373-380.
285. Nickell S.P., Sharma D. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Exp. Parasitol. 2000, 94:207-216.
286. Nimmerjahn F., Ravetch J.V. Fcgamma receptors: old friends and new family members. Immunity 2006, 24:19-28.
287. Noel W., Raes G., Hassanzadeh G.G., De Baetselier P., Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004, 20:126-133.
288. Nomizo A., Cardillo F., Postol E., de Carvalho L.P., Mengel J. V gamma 1 gammadelta T cells regulate type-1/type-2 immune responses and participate in the resistance to infection and development of heart inflammation in Trypanosoma cruzi-infected BALB/c mice. Microbes Infect. 2006, 8:880-888.
289. Norris K.A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect. Immun. 1998, 66:2460-2465.
290. Norris K.A., Bradt B., Cooper N.R., So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J. Immunol. 1991, 147:2240-2247.
291. Norris K.A., Harth G., So M. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies. Infect. Immun. 1989, 57:2372-2377.
292. Norris K.A., Schrimpf J.E. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi. Infect. Immun. 1994, 62:236-243.
293. Nunes M.P., Andrade R.M., Lopes M.F., DosReis G.A. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts. J. Immunol. 1998, 160:1313-1319.
294. Okabe K., Kipnis T.L., Calich V.L., Dias D.S. Cell-mediated cytotoxicity to Trypanosoma cruzi. I. Antibody-dependent cell mediated cytotoxicity to trypomastigote bloodstream forms. Clin. Immunol. Immunopathol. 1980, 16:344-353.
295. Olivares F.E., Heirman C., Thielemans K., Vray B. Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect. Immun. 1996, 64:3429-3434.
296. Olivares F.E., Vray B. Relationship between granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and Trypanosoma cruzi infection of murine macrophages. Parasite Immunol. 1995, 17:135-141.
297. Oliveira A.C., de Alencar B.C., Tzelepis F., Klezewsky W., da Silva R.N., Neves F.S., et al. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice. PLoS Pathog. 2010, Apr 9, 6(4):e1000870.
298. Oliveira A.C., Peixoto J.R., de Arruda L.B., Campos M.A., Gazzinelli R.T., Golenbock D.T., et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 2004, 173:5688-5696.
299. Ortiz-Ortiz L., Parks D.E., Rodriguez M., Weigle W.O. Polyclonal B lymphocyte activation during Trypanosoma cruzi infection. J. Immunol. 1980, 124:121-126.
300. Ouaissi A., Capron A. Some aspects of protozoan parasite-host cell interactions with special reference to RGD-mediated recognition process. Microb. Pathog. 1989, 6:1-5.
301. Ouaissi A., Guevara-Espinoza A., Chabe F., Gomez-Corvera R., Taibi A. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione. Immunol. Lett. 1995, 48:221-224.
302. Ouaissi A., Guilvard E., Delneste Y., Caron G., Magistrelli G., Herbault N., et al. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J. Immunol. 2002, 168:6366-6374.
303. Ouaissi M.A. Role of the RGD sequence in parasite adhesion to host cells. Parasitol. Today 1988, 4:169-173.
304. Padilla A.M., Bustamante J.M., Tarleton R.L. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 2009, 21:385-390.
305. Padilla A.M., Simpson L.J., Tarleton R.L. Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J. Immunol. 2009, 183:1245-1252.
306. Padilla A., Xu D., Martin D., Tarleton R. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells. Infect. Immun. 2007, 75:231-235.
307. Pakianathan D.R., Kuhn R.E. Interleukin-2 receptors in experimental Chagas' disease. Infect. Immun. 1992, 60:3904-3908.
308. Pangburn M.K., Ferreira V.P., Cortes C. Discrimination between host and pathogens by the complement system. Vaccine 2008, 26(Suppl. 8):I15-I21.
309. Parish I.A., Kaech S.M. Diversity in CD8(+) T cell differentiation. Curr. Opin. Immunol. 2009, 21:291-297.
310. Peluffo G., Piacenza L., Irigoin F., Alvarez M.N., Radi R. l-arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol. 2004, 20:363-369.
311. Pereira-Chioccola V.L., Acosta-Serrano A., Correia d.A.I., Ferguson M.A., Souto-Padron T., Rodrigues M.M., et al. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J. Cell Sci. 2000, 113(Pt 7):1299-1307.
312. Perez A.R., Tamae-Kakazu M., Pascutti M.F., Roggero E., Serra E., Revelli S., et al. Deficient control of Trypanosoma cruzi infection in C57BL/6 mice is related to a delayed specific IgG response and increased macrophage production of pro-inflammatory cytokines. Life Sci. 2005, 77:1945-1959.
313. Petry K., Eisen H. Chagas disease: a model for the study of autoimmune diseases. Parasitol. Today 1989, 5:111-116.
314. Piacenza L., Alvarez M.N., Peluffo G., Radi R. Fighting the oxidative assault: the Trypanosoma cruzi journey to infection. Curr. Opin. Microbiol. 2009, 12:415-421.
315. Pinge-Filho P., Tadokoro C.E., Abrahamsohn I.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol. 1999, 193:90-98.
316. Pires J.G., Milanez M.C., Pereira F.E. Histamine levels in tissues of Trypanosoma cruzi-infected mice. Agents Actions Suppl. 1992, 36:96-98.
317. Pitcovsky T.A., Buscaglia C.A., Mucci J., Campetella O. A functional network of intramolecular cross-reacting epitopes delays the elicitation of neutralizing antibodies to Trypanosoma cruzi trans-sialidase. J. Infect. Dis. 2002, 186:397-404.
318. Planelles L., Thomas M., Pulgar M., Maranon C., Grabbe S., Lopez M.C. Trypanosoma cruzi heat-shock protein-70kDa, alone or fused to the parasite KMP11 antigen, induces functional maturation of murine dendritic cells. Immunol. Cell Biol. 2002, 80:241-247.
319. Planelles L., Thomas M.C., Maranon C., Morell M., Lopez M.C. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clin. Exp. Immunol. 2003, 131:41-47.
320. Plasman N., Guillet J.G., Vray B. Impaired protein catabolism in Trypanosoma cruzi-infected macrophages: possible involvement in antigen presentation. Immunology 1995, 86:636-645.
321. Poncini C.V., Alba Soto C.D., Batalla E., Solana M.E., Gonzalez Cappa S.M. Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect. Immun. 2008, 76:2633-2641.
322. Postan M., Correa R., Ferrans V.J., Tarleton R.L. In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi. Int. Arch. Allergy Immunol. 1994, 105:251-257.
323. Ramos-Ligonio A., Lopez-Monteon A., Talamas-Rohana P., Rosales-Encina J.L. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages. Parasite Immunol. 2004, 26:409-418.
324. Redpath M.B., Carnall N., Webb H., Courel M., Amorim A., Guther M.L., et al. Conservation of genetic linkage between heat shock protein 100 and glycosylphosphatidylinositol-specific phospholipase C in Trypanosoma brucei and Trypanosoma cruzi. Mol. Biochem. Parasitol. 1998, 94:113-121.
325. Reed S.G. Immunology of Trypanosoma cruzi infections. Chem. Immunol. 1998, 70:124-143.
326. Reed S.G., Inverso J.A., Roters S.B. Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2. J. Immunol. 1984, 133:1558-1563.
327. Reed S.G., Nathan C.F., Pihl D.L., Rodricks P., Shanebeck K., Conlon P.J., et al. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J. Exp. Med. 1987, 166:1734-1746.
328. Reed S.G., Pihl D.L., Grabstein K.H. Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production. J. Immunol. 1989, 142:2067-2071.
329. Reed S.G., Grabstein K.H., Pihl D.L., Morrissey P.J. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections. J. Immunol. 1990, 145:1564-1570.
330. Reina-San-Martin B., Degrave W., Rougeot C., Cosson A., Chamond N., Cordeiro-Da-Silva A., et al. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat. Med. 2000, 6:890-897.
331. Rodrigues M.M., Ribeirao M., Boscardin S.B. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol. Lett. 2000, 73:43-50.
332. Romanha A.J., Alves R.O., Murta S.M., Silva J.S., Ropert C., Gazzinelli R.T. Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure. J. Infect. Dis. 2002, 186:823-828.
333. Ropert C., Ferreira L.R., Campos M.A., Procopio D.O., Travassos L.R., Ferguson M.A., et al. Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect. 2002, 4:1015-1025.
334. Rottenberg M., Cardoni R.L., Andersson R., Segura E.L., Orn A. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand. J. Immunol. 1988, 28:573-582.
335. Rottenberg M.E., Bakhiet M., Olsson T., Kristensson K., Mak T., Wigzell H., et al. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 1993, 61:5129-5133.
336. Rottenberg M.E., Castanos-Velez E., de Mesquita R., Laguardia O.G., Biberfeld P., Orn A. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Eur. J. Immunol. 1996, 26:3203-3213.
337. Rowland E.C., Kuhn R.E. Suppression of cellular responses in mice during Trypanosoma cruzi infections. Infect. Immun. 1978, 20:393-397.
338. Rytel M.W., Marsden P.D. Induction of an interferon-like inhibitor by Trypanosoma cruzi infection in mice. Am. J. Trop. Med. Hyg. 1970, 19:929-931.
339. Saeftel M., Fleischer B., Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect. Immun. 2001, 69:2252-2259.
340. Sakai T., Hisaeda H., Ishikawa H., Maekawa Y., Zhang M., Nakao Y., et al. Expression and role of heat-shock protein 65 (HSP65) in macrophages during Trypanosoma cruzi infection: involvement of HSP65 in prevention of apoptosis of macrophages. Microbes Infect. 1999, 1:419-427.
341. Sanchez G., Zulantay I., Gajardo M., Venegas J., Villanueva R., Perez A., et al. Immunophenotyping of peripheral blood lymphocytes from Chilean chronic chagasic patients by flow cytometry. Rev. Med. Chil. 2002, 130:363-367.
342. Santiago H.C., Feng C.G., Bafica A., Roffe E., Arantes R.M., Cheever A., et al. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth. J. Immunol. 2005, 175:8165-8172.
343. Santos Lima E.C., Minoprio P. Chagas' disease is attenuated in mice lacking gamma delta T cells. Infect. Immun. 1996, 64:215-221.
344. Santos-Lima E.C., Vasconcellos R., Reina-San-Martin B., Fesel C., Cordeiro-Da-Silva A., Berneman A., et al. Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection. Eur. J. Immunol. 2001, 31:634-645.
345. Sardinha L.R., Elias R.M., Mosca T., Bastos K.R., Marinho C.R., D'Imperio Lima M.R., et al. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect. Immun. 2006, 74:2031-2042.
346. Sardinha L.R., Mosca T., Elias R.M., do Nascimento R.S., Goncalves L.A., Bucci D.Z., et al. The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice. PLoS Negl. Trop. Dis. 2010, 4:e578.
347. Sathler-Avelar R., Lemos E.M., Reis D.D., Medrano-Mercado N., Araujo-Jorge T.C., Antas P.R., et al. Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand. J. Immunol. 2003, 58:655-663.
348. Sathler-Avelar R., Vitelli-Avelar D.M., Teixeira-Carvalho A., Martins-Filho O.A. Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?. Mem. Inst. Oswaldo Cruz 2009, 104(Suppl. 1):246-251.
349. Savino W. The thymus is a common target organ in infectious diseases. PLoS Pathog. 2006, 2:e62.
350. Scharfstein J., Schmitz V., Morandi V., Capella M.M., Lima A.P., Morrot A., et al. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J. Exp. Med. 2000, 192:1289-1300.
351. Scharfstein J., Schmitz V., Svensjo E., Granato A., Monteiro A.C. Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand. J. Immunol. 2007, 66:128-136.
352. Schmitz V., Svensjo E., Serra R.R., Teixeira M.M., Scharfstein J. Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors. J. Leukoc. Biol. 2009, 85:1005-1014.
353. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraser-Reid B., Grusby M.J., et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999, 283:225-229.
354. Schoneck R., Plumas-Marty B., Taibi A., Billaut-Mulot O., Loyens M., Gras-Masse H., et al. Trypanosoma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S-transferases. Biol. Cell. 1994, 80:1-10.
355. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
356. Scott M.T., Goss-Sampson M. Restricted IgG isotype profiles in T. cruzi infected mice and Chagas' disease patients. Clin. Exp. Immunol. 1984, 58:372-379.
357. Scott M.T., Moyes L. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver. Clin. Exp. Immunol. 1982, 48:754-757.
358. Semple J.W., Freedman J. Platelets and innate immunity. Cell Mol. Life Sci. 2010, 67:499-511.
359. Shaw K.T., Mawji Y., Stevenson M.M., Kongshavn P.A. Cells within the vascular system capable of mediating trypanocidal activity in vitro. Infect. Immun. 1991, 59:3143-3150.
360. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
361. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
362. Silva G.K., Gutierrez F.R., Guedes P.M., Horta C.V., Cunha L.D., Mineo T.W., et al. Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J. Immunol. 2010, 184:1148-1152.
363. Silva J.S., Twardzik D.R., Reed S.G. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J. Exp. Med. 1991, 174:539-545.
364. Snapper C.M., Paul W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987, 236:944-947.
365. Soehnlein O., Weber C., Lindbom L. Neutrophil granule proteins tune monocytic cell function. Trends Immunol. 2009, 30:538-546.
366. Sonnenfeld G., Kierszenbaum F. Increased serum levels of an interferon-like activity during the acute period of experimental infection with different strains of Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 1981, 30:1189-1191.
367. Soong L., Tarleton R.L. Selective suppressive effects of Trypanosoma cruzi infection on IL-2, c-myc, and c-fos gene expression. J. Immunol. 1992, 149:2095-2102.
368. Soong L., Tarleton R.L. Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur. J. Immunol. 1994, 24:16-23.
369. Souza P.E., Rocha M.O., Rocha-Vieira E., Menezes C.A., Chaves A.C., Gollob K.J., et al. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect. Immun. 2004, 72:5283-5291.
370. Stempin C., Giordanengo L., Gea S., Cerban F. Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J. Leukoc. Biol. 2002, 72:727-734.
371. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006, 6:9-20.
372. Stryker G.A., Nickell S.P. Trypanosoma cruzi: exposure of murine cells to live parasites in vitro leads to enhanced surface class I MHC expression which is type I interferon-dependent. Exp. Parasitol. 1995, 81:564-573.
373. Takehara H.A., Mota I. The possible mechanism of action of IgG antibodies and platelets protecting against Trypanosoma cruzi infection. Braz. J. Med. Biol. Res. 1991, 24:759-765.
374. Talmadge J.E. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin. Cancer Res. 2007, 13:5243-5248.
375. Tambourgi D.V., Kipnis T.L., Dias D.S. Trypanosoma cruzi: antibody-dependent killing of bloodstream trypomastigotes by mouse bone marrow-derived mast cells and by mastocytoma cells. Exp. Parasitol. 1989, 68:192-201.
376. Tambourgi D.V., Kipnis T.L., da Silva W.D., Joiner K.A., Sher A., Heath S., et al. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. Infect. Immun. 1993, 61:3656-3663.
377. Tambourgi D.V., Cavinato R.A., De Abreu C.M., Peres B.A., Kipnis T.L. Detection of Trypanosoma-decay accelerating factor antibodies in mice and humans infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 1995, 52:516-520.
378. Tarleton R.L. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells. J. Immunol. 1988, 140:2763-2768.
379. Tarleton R.L. Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. J. Immunol. 1988, 140:2769-2773.
380. Tarleton R.L., Kuhn R.E. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. J. Immunol. 1984, 133:1570-1575.
381. Tarleton R.L., Kuhn R.E. Measurement of parasite-specific immune responses in vitro: evidence for suppression of the antibody response to Trypanosoma cruzi. Eur. J. Immunol. 1985, 15:845-850.
382. Tarleton R.L., Koller B.H., Latour A., Postan M. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992, 356:338-340.
383. Tarleton R.L., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 1994, 62:1820-1829.
384. Tarleton R.L., Grusby M.J., Postan M., Glimcher L.H. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 1996, 8:13-22.
385. Tarleton R.L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 2007, 19:430-434.
386. Taylor P.R., Gordon S., Martinez-Pomares L. The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 2005, 26:104-110.
387. Thedrez A., Sabourin C., Gertner J., Devilder M.C., Allain-Maillet S., Fournie J.J., et al. Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?. Immunol. Rev. 2007, 215:123-135.
388. Tomlinson S., Pontes de Carvalho L.C., Vandekerckhove F., Nussenzweig V. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J. Immunol. 1994, 153:3141-3147.
389. Tomlinson S., Raper J. Natural human immunity to trypanosomes. Parasitol. Today 1998, 14:354-359.
390. Torrico F., Heremans H., Rivera M.T., Van Marck E., Billiau A., Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 1991, 146:3626-3632.
391. Towbin H., Rosenfelder G., Wieslander J., Avila J.L., Rojas M., Szarfman A., et al. Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes. J. Exp. Med. 1987, 166:419-432.
392. Tribulatti M.V., Mucci J., Van Rooijen N., Leguizamon M.S., Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Infect. Immun. 2005, 73:201-207.
393. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
394. Trocoli Torrecilhas A.C., Tonelli R.R., Pavanelli W.R., da Silva J.S., Schumacher R.I., de Souza W., et al. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 2009, 11:29-39.
395. Truyens C., Angelo-Barrios A., Torrico F., Van Damme J., Heremans H., Carlier Y. Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect. Immun. 1994, 62:692-696.
396. Truyens C., Rivera M.T., Ouaissi A., Carlier Y. High circulating levels of fibronectin and antibodies against its RGD adhesion site during mouse Trypanosoma cruzi infection: relation to survival. Exp. Parasitol. 1995, 80:499-506.
397. Truyens C., Torrico F., Lucas R., De Baetselier P., Buurman W.A., Carlier Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Infect. Immun. 1999, 67:5579-5586.
398. Tsan M.F., Gao B. Heat shock proteins and immune system. J. Leukoc. Biol. 2009, 85:905-910.
399. Tsutsui H., Yoshimoto T., Hayashi N., Mizutani H., Nakanishi K. Induction of allergic inflammation by interleukin-18 in experimental animal models. Immunol. Rev. 2004, 202:115-138.
400. Tzelepis F., de Alencar B.C., Penido M.L., Gazzinelli R.T., Persechini P.M., Rodrigues M.M. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naïve or vaccinated mice. Infect. Immun. 2006, 74:2477-2481.
401. Tzelepis F., Persechini P.M., Rodrigues M.M. Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load. PLoS One 2007, 2:e393.
402. Uhlin M., Masucci M., Levitsky V. Is the activity of partially agonistic MHC: peptide ligands dependent on the quality of immunological help?. Scand. J. Immunol. 2006, 64:581-587.
403. Umekita L.F., Mota I. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors. Parasite Immunol. 1989, 11:561-566.
404. Umekita L.F., Mota I. Role of platelets in the in vivo removal of T. cruzi from circulation. Braz. J. Med. Biol. Res. 1990, 23:593-596.
405. Umekita L.F., Mota I. How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?. Braz. J. Med. Biol. Res. 2000, 33:253-258.
406. Umekita L.F., Takehara H.A., Mota I. Role of the antibody Fc in the immune clearance of Trypanosoma cruzi. Immunol. Lett. 1988, 17:85-89.
407. Umezawa E.S., Shikanai-Yasuda M.A., Stolf A.M. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease. J. Clin. Lab Anal. 1996, 10:407-413.
408. Une C., Andersson J., Eloranta M.L., Sunnemark D., Harris R.A., Orn A. Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-gamma) display different kinetics during experimental infection with Trypanosoma cruzi. Clin. Exp. Immunol. 2000, 121:499-505.
409. Une C., Andersson J., Orn A. Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi. Clin. Exp. Immunol. 2003, 134:195-201.
410. Vaena D.A., Blader I.J., Fisher M., Boothroyd J.C., Burleigh B.A. Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 2002, 277:639-644.
411. Valck C., Ramirez G., Lopez N., Ribeiro C.H., Maldonado I., Sanchez G., et al. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Mol. Immunol 2010, 47(7-8):1516-1521.
412. Van Overtvelt L., Andrieu M., Verhasselt V., Connan F., Choppin J., Vercruysse V., et al. Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int. Immunol. 2002, 14:1135-1144.
413. Van Overtvelt L., Vanderheyde N., Verhasselt V., Ismaili J., De Vos L., Goldman M., et al. Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. Immun. 1999, 67:4033-4040.
414. Van Voorhis W.C. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J. Immunol. 1992, 148:239-248.
415. Vandekerckhove F., Darji A., Rivera M.T., Carlier Y., Vray B., Billiau A., et al. Modulation of T-cell responsiveness during Trypanosoma cruzi infection: analysis in different lymphoid compartments. Parasite Immunol. 1994, 16:77-85.
416. Venturini G., Salvati L., Muolo M., Colasanti M., Gradoni L., Ascenzi P. Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 2000, 270:437-441.
417. Vercelli C.A., Hidalgo A.M., Hyon S.H., Argibay P.F. Trypanosoma cruzi trans-sialidase inhibits human lymphocyte proliferation by nonapoptotic mechanisms: implications in pathogenesis and transplant immunology. Transplant. Proc. 2005, 37:4594-4597.
418. Vespa G.N., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 1994, 62:5177-5182.
419. Villalta F., Kierszenbaum F. Role of polymorphonuclear cells in Chagas' disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human neutrophils. J. Immunol. 1983, 131:1504-1510.
420. Villalta F., Kierszenbaum F. Role of inflammatory cells in Chagas' disease. I. Uptake and mechanism of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human eosinophils. J. Immunol. 1984, 132:2053-2058.
421. Villalta F., Kierszenbaum F. Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (Trypanosoma cruzi) by human neutrophils. J. Immunol. 1986, 137:1703-1707.
422. Virgin H.W., Levine B. Autophagy genes in immunity. Nat. Immunol. 2009, 10:461-470.
423. Vitelli-Avelar D.M., Sathler-Avelar R., Dias J.C., Pascoal V.P., Teixeira-Carvalho A., Lage P.S., et al. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand. J. Immunol. 2005, 62:297-308.
424. Vitelli-Avelar D.M., Sathler-Avelar R., Massara R.L., Borges J.D., Lage P.S., Lana M., et al. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?. Clin. Exp. Immunol. 2006, 145:81-92.
425. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
426. Waghabi M.C., Keramidas M., Bailly S., Degrave W., Mendonca-Lima L., Soeiro M.N., et al. Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. Am. J. Pathol. 2005, 167:993-1003.
427. Waghabi M.C., Keramidas M., Feige J.J., Araujo-Jorge T.C., Bailly S. Activation of transforming growth factor beta by Trypanosoma cruzi. Cell Microbiol. 2005, 7:511-517.
428. Wahl S.M., Hunt D.A., Wong H.L., Dougherty S., McCartney-Francis N., Wahl L.M., et al. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 1988, 140:3026-3032.
429. Willment J.A., Brown G.D. C-type lectin receptors in antifungal immunity. Trends Microbiol. 2008, 16:27-32.
430. Wizel B., Nunes M., Tarleton R.L. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J. Immunol. 1997, 159:6120-6130.
431. Wizel B., Palmieri M., Mendoza C., Arana B., Sidney J., Sette A., et al. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J. Clin. Invest. 1998, 102:1062-1071.
432. Wood K.L., Twigg H.L., Doseff A.I. Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci. 2009, 14:3771-3781.
433. Wu L., Gabriel C.L., Parekh V.V., Van Kaer L. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens 2009, 73:535-545.
434. Yang D., de la R.G., Tewary P., Oppenheim J.J. Alarmins link neutrophils and dendritic cells. Trends Immunol. 2009, 30:531-537.
435. Yeaman M.R. Platelets in defense against bacterial pathogens. Cell Mol. Life Sci. 2010, 67:525-544.
436. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An. Acad. Bras. Cienc. 2006, 78:87-111.
437. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
438. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740.
439. Zuniga E., Montes C., Barbieri G., Gruppi A. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients. Clin. Immunol. 1999, 93:81-89.
440. Zuniga E., Motran C., Montes C.L., Diaz F.L., Bocco J.L., Gruppi A. Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection. Clin. Exp. Immunol. 2000, 119:507-515.
441. Zuniga E., Acosta-Rodriguez E., Merino M.C., Montes C., Gruppi A. Depletion of immature B cells during Trypanosoma cruzi infection: involvement of myeloid cells and the cyclooxygenase pathway. Eur. J. Immunol. 2005, 35:1849-1858.
442. Zychlinsky A., Karim M., Nonacs R., Young J.D. A homogeneous population of lymphokine-activated killer (LAK) cells is incapable of killing virus-, bacteria-, or parasite-infected macrophages. Cell Immunol. 1990, 125:261-267.